Evidence map›Paper›PMID 25550811›Full record

ArticleInternational journal of clinical and experimental pathology2014

TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1.

Qing-Qing Zhang, Ming-Yi Xu, Yin Qu, Jun-Jie Hu, Zheng-Hong Li, Qi-Di Zhang, Lun-Gen Lu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Observational
  10. Review
  11. The Roles and Mechanisms of lncRNAs in Liver Fibrosis.International journal of molecular sciences · 2020
    Review
  12. Non-Coding RNAs as New Therapeutic Targets in the Context of Renal Fibrosis.International journal of molecular sciences · 2019
    Review
  13. [Research advancement of long non-coding RNAs in liver fibrosis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019
    Article
  14. Review
  15. Article
  16. DNA methylation regulated gene expression in organ fibrosis.Biochimica et biophysica acta. Molecular basis of disease · 2017
    Review
  17. [Influence of long non - coding RNA on liver diseases and related mechanisms].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017
    Article
  18. Article
  19. Circulating exosomes and exosomal lncRNA HIF1A-AS1 in atherosclerosis.International journal of clinical and experimental pathology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qing-Qing ZhangDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Ming-Yi XuDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Yin QuDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Jun-Jie HuDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Zheng-Hong LiDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Qi-Di ZhangDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Lun-Gen LuDepartment of Gastroenterology, Shanghai First People's Hospital, Shanghai Jiao-Tong University School of Medicine Shanghai 200080, China.
Shanghai First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activated Hepatic stellate cells (HSCs) play a critical role in liver fibrosis and a lot of efforts have been made to dissect the underlying mechanism involved in activation of HSCs. However, the underlying mechanism remains douteux up to now. In the present study, we found that TET3, one member of ten-eleven translocation (TET) protein family, reduced significantly in HSCs LX-2 activated by TGF-β1. To study the function of TET3 in activation of HSCs, knockdown was performed by RNA interference. Results showed that cell proliferation rise significantly and cell apoptosis reduce obviously after knockdown of TET3. Meanwhile, IHC showed that the expression of α-SMA rise significantly compared to control. These results indicated that TET3 is closely associated with the activation of HSCs. Further studies found that long non-coding RNA HIF1A-AS1 was reduced significantly in LX-2 cell after treatment with siRNA for TET3. The result hinted that TET3 activate HSCs through modulating the expression of HIF1A-AS1. To confirm this hypothesis, RNA interference was performed to silence the HIF1A-AS1. Results showed that HIF1A-AS1 silencing lead to enhancing in cell proliferation and declining apoptosis. Taken together, TET3 can mediate the activation of HSCs via modulating the expression of the long non-coding RNA HIF1A-AS1.

Indexed as

ApoptosisCell LineCell ProliferationDioxygenasesHepatic Stellate CellsHumansHypoxia-Inducible Factor 1, alpha SubunitLiver CirrhosisRNA, Long NoncodingTransforming Growth Factor beta1DioxygenasesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitRNA, Long NoncodingTET3 protein, humanTransforming Growth Factor beta1HIF1A-AS1HSCsLiver fibrosislong non-coding RNATET3

Identifiers

PMID25550811
PMCPMC4270585
OpenAlexW60246887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.